Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 1.010
Filtrer
1.
Nat Commun ; 15(1): 5597, 2024 Jul 03.
Article de Anglais | MEDLINE | ID: mdl-38961064

RÉSUMÉ

Cyclin-dependent kinases 4 and 6 (CDK4/6) play a pivotal role in cell cycle and cancer development. Targeting CDK4/6 has demonstrated promising effects against breast cancer. However, resistance to CDK4/6 inhibitors (CDK4/6i), such as palbociclib, remains a substantial challenge in clinical settings. Using high-throughput combinatorial drug screening and genomic sequencing, we find that the microphthalmia-associated transcription factor (MITF) is activated via O-GlcNAcylation by O-GlcNAc transferase (OGT) in palbociclib-resistant breast cancer cells and tumors. Mechanistically, O-GlcNAcylation of MITF at Serine 49 enhances its interaction with importin α/ß, thus promoting its translocation to nuclei, where it suppresses palbociclib-induced senescence. Inhibition of MITF or its O-GlcNAcylation re-sensitizes resistant cells to palbociclib. Moreover, clinical studies confirm the activation of MITF in tumors from patients who are palbociclib-resistant or undergoing palbociclib treatment. Collectively, our studies shed light on the mechanism regulating palbociclib resistance and present clinical evidence for developing therapeutic approaches to treat CDK4/6i-resistant breast cancer patients.


Sujet(s)
Tumeurs du sein , Kinase-4 cycline-dépendante , Kinase-6 cycline-dépendante , Résistance aux médicaments antinéoplasiques , Facteur de transcription associé à la microphtalmie , N-acetylglucosaminyltransferase , Pipérazines , Pyridines , Humains , Kinase-4 cycline-dépendante/métabolisme , Kinase-4 cycline-dépendante/antagonistes et inhibiteurs , Tumeurs du sein/métabolisme , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/génétique , Tumeurs du sein/anatomopathologie , Kinase-6 cycline-dépendante/métabolisme , Kinase-6 cycline-dépendante/antagonistes et inhibiteurs , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Femelle , Résistance aux médicaments antinéoplasiques/effets des médicaments et des substances chimiques , Pipérazines/pharmacologie , Pyridines/pharmacologie , Lignée cellulaire tumorale , N-acetylglucosaminyltransferase/métabolisme , N-acetylglucosaminyltransferase/antagonistes et inhibiteurs , N-acetylglucosaminyltransferase/génétique , Animaux , Souris , Inhibiteurs de protéines kinases/pharmacologie , Tests d'activité antitumorale sur modèle de xénogreffe
2.
Orphanet J Rare Dis ; 19(1): 226, 2024 Jun 06.
Article de Anglais | MEDLINE | ID: mdl-38844942

RÉSUMÉ

BACKGROUND: Waardenburg syndrome (WS) is a rare genetic disorder mainly characterized by hearing loss and pigmentary abnormalities. Currently, seven causative genes have been identified for WS, but clinical genetic testing results show that 38.9% of WS patients remain molecularly unexplained. In this study, we performed multi-data integration analysis through protein-protein interaction and phenotype-similarity to comprehensively decipher the potential causative factors of undiagnosed WS. In addition, we explored the association between genotypes and phenotypes in WS with the manually collected 443 cases from published literature. RESULTS: We predicted two possible WS pathogenic genes (KIT, CHD7) through multi-data integration analysis, which were further supported by gene expression profiles in single cells and phenotypes in gene knockout mouse. We also predicted twenty, seven, and five potential WS pathogenic variations in gene PAX3, MITF, and SOX10, respectively. Genotype-phenotype association analysis showed that white forelock and telecanthus were dominantly present in patients with PAX3 variants; skin freckles and premature graying of hair were more frequently observed in cases with MITF variants; while aganglionic megacolon and constipation occurred more often in those with SOX10 variants. Patients with variations of PAX3 and MITF were more likely to have synophrys and broad nasal root. Iris pigmentary abnormality was more common in patients with variations of PAX3 and SOX10. Moreover, we found that patients with variants of SOX10 had a higher risk of suffering from auditory system diseases and nervous system diseases, which were closely associated with the high expression abundance of SOX10 in ear tissues and brain tissues. CONCLUSIONS: Our study provides new insights into the potential causative factors of WS and an alternative way to explore clinically undiagnosed cases, which will promote clinical diagnosis and genetic counseling. However, the two potential disease-causing genes (KIT, CHD7) and 32 potential pathogenic variants (PAX3: 20, MITF: 7, SOX10: 5) predicted by multi-data integration in this study are all computational predictions and need to be further verified through experiments in follow-up research.


Sujet(s)
Facteur de transcription associé à la microphtalmie , Facteurs de transcription SOX-E , Syndrome de Waardenburg , Syndrome de Waardenburg/génétique , Humains , Facteur de transcription associé à la microphtalmie/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Facteurs de transcription SOX-E/génétique , Facteurs de transcription SOX-E/métabolisme , Facteur de transcription PAX3/génétique , Facteur de transcription PAX3/métabolisme , Souris , Animaux , Phénotype , Génotype , Mutation/génétique
3.
Sci Rep ; 14(1): 13619, 2024 06 13.
Article de Anglais | MEDLINE | ID: mdl-38871989

RÉSUMÉ

The slow-developing neurological disorder Alzheimer's disease (AD) has no recognized etiology. A bioinformatics investigation verified copper metabolism indicators for AD development. GEO contributed AD-related datasets GSE1297 and GSE5281. Differential expression analysis and WGCNA confirmed biomarker candidate genes. Each immune cell type in AD and control samples was scored using single sample gene set enrichment analysis. Receiver Operating Characteristic (ROC) analysis, short Time-series Expression Miner (STEM) grouping, and expression analysis between control and AD samples discovered copper metabolism indicators that impacted AD progression. We test clinical samples and cellular function to ensure study correctness. Biomarker-targeting miRNAs and lncRNAs were predicted by starBase. Trust website anticipated biomarker-targeting transcription factors. In the end, Cytoscape constructed the TF/miRNA-mRNA and lncRNA-miRNA networks. The DGIdb database predicted biomarker-targeted drugs. We identified 57 differentially expressed copper metabolism-related genes (DE-CMRGs). Next, fourteen copper metabolism indicators impacting AD progression were identified: CCK, ATP6V1E1, SYT1, LDHA, PAM, HPRT1, SCG5, ATP6V1D, GOT1, NFKBIA, SPHK1, MITF, BRCA1, and CD38. A TF/miRNA-mRNA regulation network was then established with two miRNAs (hsa-miR-34a-5p and 34c-5p), six TFs (NFKB1, RELA, MYC, HIF1A, JUN, and SP1), and four biomarkers. The DGIdb database contained 171 drugs targeting ten copper metabolism-relevant biomarkers (BRCA1, MITF, NFKBIA, CD38, CCK2, HPRT1, SPHK1, LDHA, SCG5, and SYT1). Copper metabolism biomarkers CCK, ATP6V1E1, SYT1, LDHA, PAM, HPRT1, SCG5, ATP6V1D, GOT1, NFKBIA, SPHK1, MITF, BRCA1, and CD38 alter AD progression, laying the groundwork for disease pathophysiology and novel AD diagnostic and treatment.


Sujet(s)
Maladie d'Alzheimer , Marqueurs biologiques , Cuivre , Facteur de transcription associé à la microphtalmie , Humains , Maladie d'Alzheimer/métabolisme , Maladie d'Alzheimer/génétique , Cuivre/métabolisme , Marqueurs biologiques/métabolisme , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Réseaux de régulation génique , Biologie informatique/méthodes , ARN long non codant/génétique , ARN long non codant/métabolisme , microARN/génétique , microARN/métabolisme , Analyse de profil d'expression de gènes
4.
Int J Mol Sci ; 25(11)2024 May 29.
Article de Anglais | MEDLINE | ID: mdl-38892131

RÉSUMÉ

Petanin, an acylated anthocyanin from the Solanaceae family, shows potential in tyrosinase inhibitory activity and anti-melanogenic effects; however, its mechanism remains unclear. Therefore, to investigate the underlying mechanism of petanin's anti-melanogenic effects, the enzyme activity, protein expression and mRNA transcription of melanogenic and related signaling pathways in zebrafish using network pharmacology, molecular docking and molecular dynamics simulation were combined for analysis. The results showed that petanin could inhibit tyrosinase activity and melanogenesis, change the distribution and arrangement of melanocytes and the structure of melanosomes, reduce the activities of catalase (CAT) and peroxidase (POD) and enhance the activity of glutathione reductase (GR). It also up-regulated JNK phosphorylation, inhibited ERK/RSK phosphorylation and down-regulated CREB/MITF-related protein expression and mRNA transcription. These results were consistent with the predictions provided through network pharmacology and molecular docking. Thus, petanin could inhibit the activity of tyrosinase and the expression of tyrosinase by inhibiting and negatively regulating the tyrosinase-related signaling pathway ERK/CREB/MITF through p-JNK. In conclusion, petanin is a good tyrosinase inhibitor and anti-melanin natural compound with significant market prospects in melanogenesis-related diseases and skin whitening cosmetics.


Sujet(s)
Mélanines , Simulation de docking moléculaire , Danio zébré , Animaux , Danio zébré/métabolisme , Mélanines/métabolisme , Mélanines/biosynthèse , Phosphorylation , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme , Monophenol monooxygenase/métabolisme , Monophenol monooxygenase/antagonistes et inhibiteurs , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Mélanocytes/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques
5.
Eur J Cell Biol ; 103(2): 151421, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38776620

RÉSUMÉ

The Microphthalmia-associated Transcription Factor (MITF) governs numerous cellular and developmental processes. In mice, it promotes specification and differentiation of the retinal pigmented epithelium (RPE), and in humans, some mutations in MITF induce congenital eye malformations. Herein, we explore the function and regulation of Mitf in Drosophila eye development and uncover two roles. We find that knockdown of Mitf results in retinal displacement (RDis), a phenotype associated with abnormal eye formation. Mitf functions in the peripodial epithelium (PE), a retinal support tissue akin to the RPE, to suppress RDis, via the Hippo pathway effector Yorkie (Yki). Yki physically interacts with Mitf and can modify its transcriptional activity in vitro. Severe loss of Mitf, instead, results in the de-repression of retinogenesis in the PE, precluding its development. This activity of Mitf requires the protein phosphatase 2 A holoenzyme STRIPAK-PP2A, but not Yki; Mitf transcriptional activity is potentiated by STRIPAK-PP2A in vitro and in vivo. Knockdown of STRIPAK-PP2A results in cytoplasmic retention of Mitf in vivo and in its decreased stability in vitro, highlighting two potential mechanisms for the control of Mitf function by STRIPAK-PP2A. Thus, Mitf functions in a context-dependent manner as a key determinant of form and fate in the Drosophila eye progenitor epithelium.


Sujet(s)
Protéines de Drosophila , Facteur de transcription associé à la microphtalmie , Protéines de signalisation YAP , Animaux , Protéines de Drosophila/métabolisme , Protéines de Drosophila/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Protéines de signalisation YAP/métabolisme , Protéines de signalisation YAP/génétique , Transactivateurs/métabolisme , Transactivateurs/génétique , Protéines nucléaires/métabolisme , Protéines nucléaires/génétique , Oeil/métabolisme , Oeil/croissance et développement , Protein Phosphatase 2/métabolisme , Protein Phosphatase 2/génétique , Drosophila melanogaster/métabolisme , Drosophila melanogaster/génétique , Épithélium/métabolisme , Différenciation cellulaire , Protéines à homéodomaine
6.
J Ethnopharmacol ; 332: 118348, 2024 Oct 05.
Article de Anglais | MEDLINE | ID: mdl-38762211

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: Tokishakuyakusan (TSS), a traditional Kampo medicine, can effectively alleviate symptoms unique to women, such as menstrual pain and menopausal symptoms, and this effect is believed to be related to its ability to increase the secretion of female hormones. TSS is also believed to be effective against skin pigmentation. However, no studies have examined the effect of TSS on pigmentation. AIM OF THE STUDY: In this study, we conducted basic research to determine the effects of TSS on pigmentation. MATERIALS AND METHODS: Female HRM-2 mice were given free access to a normal diet or a TSS-containing diet for 7 weeks. For 3 weeks starting from the 4th week of treatment, the back of the skin was irradiated with ultraviolet (UV) light, and the melanin level was measured. The expression levels of melanogenesis-related genes and inflammatory markers in the skin were analyzed. RESULTS: The melanin level in the skin of the mice exposed to UV radiation was approximately three times greater than that in the skin of the mice in the non-UV-irradiated group, confirming pigmentation due to UV irradiation. The protein expression levels of tyrosinase (Tyr), tyrosinase-related protein-1 (Tyrp1), and dopachrome tautomerase (Dct), which are important for melanin production, were significantly greater in the UV irradiation group than in the non-UV irradiation group. In contrast, the amount of skin melanin in the mice treated with TSS was significantly lower than that in the UV-irradiated group, and the expression levels of melanogenesis-related enzymes were also lower. Furthermore, TSS significantly decreased the expression of microphthalmia transcription factor (Mitf), a transcription factor for melanogenesis-related enzymes, and the inflammatory cytokines interleukin-1ß and interleukin-6. CONCLUSIONS: TSS inhibits melanin production in melanocytes by suppressing the increase in the expression of melanogenesis-related enzymes caused by UV irradiation. These findings suggested that this effect of TSS is exerted through the combined regulation of MITF expression and anti-inflammatory responses.


Sujet(s)
Médicaments issus de plantes chinoises , Mélanines , Monophenol monooxygenase , Pigmentation de la peau , Rayons ultraviolets , Animaux , Rayons ultraviolets/effets indésirables , Mélanines/biosynthèse , Mélanines/métabolisme , Pigmentation de la peau/effets des médicaments et des substances chimiques , Pigmentation de la peau/effets des radiations , Femelle , Souris , Monophenol monooxygenase/métabolisme , Médicaments issus de plantes chinoises/pharmacologie , Peau/effets des médicaments et des substances chimiques , Peau/effets des radiations , Peau/métabolisme , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Médecine kampo , Intramolecular oxidoreductases/métabolisme , Intramolecular oxidoreductases/génétique , Souris hairless , , Glycoprotéines membranaires , Oxidoreductases
7.
Fr J Urol ; 34(2): 102569, 2024 Mar.
Article de Anglais | MEDLINE | ID: mdl-38717457

RÉSUMÉ

INTRODUCTION: Microphthalmia Transfactor Family (MiTF) translocation renal cell carcinomas (RCCs) represent a rare subtype of renal cell cancers. They are diagnosed in young patients and have a poor prognosis. The aim of our study was to analyze the clinical and pathological features of patients with MiTF RCC. MATERIAL AND METHOD: We performed a retrospective, monocentric, descriptive study including all patients operated for RCC between January 2015 and January 2023. The diagnosis of MiTF RCC was suspected by immunohistochemistry (IHC) and confirmed by fluorescent in situ hybridization (FISH). Survival data according to histological subtype (MiTF versus ccRCC) were analyzed using the Kaplan-Meier method and compared using a log-rank test. The primary endpoint was recurrence-free survival (RFS). A descriptive cohort analysis was performed. RESULTS: Of the 960 patients included, 19 (2%) had FISH-confirmed MiTF tumors. The median age at diagnosis was 42 years [18-75], the sex ratio was 1.11 females for 1 male, and 4 (21%) patients were immediately metastatic. Median RFS was 21months for patients in the MiTF group and was significantly lower than that of ccRCC patients, HR=4.33 [CI95% 2.06; 9.10; P<0.001]. Of the 11 patients with cT1-T2 tumors, 9 (81.8%) were treated with nephron sparing-surgery, with 2 (22.2%) harbored local recurrence. CONCLUSION: Our study shows that patients with MiTF translocation RCC have a significantly lower RFS than non-MiTF RCC patients. Nephron sparing surgery must be weighted by the high risk of recurrence in this particularly young population.


Sujet(s)
Néphrocarcinome , Tumeurs du rein , Facteur de transcription associé à la microphtalmie , Translocation génétique , Humains , Tumeurs du rein/anatomopathologie , Tumeurs du rein/génétique , Tumeurs du rein/mortalité , Tumeurs du rein/chirurgie , Néphrocarcinome/anatomopathologie , Néphrocarcinome/génétique , Néphrocarcinome/mortalité , Néphrocarcinome/chirurgie , Mâle , Femelle , Facteur de transcription associé à la microphtalmie/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Adulte , Adulte d'âge moyen , Études rétrospectives , Sujet âgé , Jeune adulte , Adolescent
8.
Front Biosci (Landmark Ed) ; 29(5): 194, 2024 May 20.
Article de Anglais | MEDLINE | ID: mdl-38812330

RÉSUMÉ

BACKGROUNDS: Melanogenesis, regulated by genetic, hormonal, and environmental factors, occurs in melanocytes in the basal layer of the epidermis. Dysregulation of this process can lead to various skin disorders, such as hyperpigmentation and hypopigmentation. Therefore, the present study investigated the effect of ultrasonic-assisted ethanol extract (SHUE) from Sargassum horneri (S. horneri), brown seaweed against melanogenesis in α-melanocyte-stimulating hormone (MSH)-stimulated B16F10 murine melanocytes. METHODS: Firstly, yield and proximate compositional analysis of the samples were conducted. The effect of SHUE on cell viability has been evaluated by using 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. After that, the melanin content and cellular tyrosinase activity in α-MSH-stimulated B16F10 murine melanocytes were examined. Western blot analysis was carried out to investigate the protein expression levels of microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein-1 (TRP1), and tyrosinase-related protein-2 (TRP2). In addition, the effect of extracellular signal-regulated kinase (ERK) on the melanogenesis process was assessed via Western blotting. RESULTS: As per the analysis, SHUE contained the highest average yield on a dry basis at 28.70 ± 3.21%. The findings showed that SHUE reduced the melanin content and cellular tyrosinase activity in α-MSH-stimulated B16F10 murine melanocytes. Additionally, the expression levels of MITF, TRP1, and TRP2 protein were significantly downregulated by SHUE treatment in α-MSH-stimulated B16F10 murine melanocytes. Moreover, SHUE upregulated the phosphorylation of ERK and AKT in α-MSH-stimulated B16F10 murine melanocytes. In addition, experiments conducted using the ERK inhibitor (PD98059) revealed that the activity of SHUE depends on the ERK signaling cascade. CONCLUSION: These results suggest that SHUE has an anti-melanogenic effect and can be used as a material in the formulation of cosmetics related to whitening and lightening.


Sujet(s)
Éthanol , Mélanines , Mélanocytes , Monophenol monooxygenase , Sargassum , Animaux , Sargassum/composition chimique , Mélanines/biosynthèse , Mélanines/métabolisme , Monophenol monooxygenase/métabolisme , Monophenol monooxygenase/antagonistes et inhibiteurs , Mélanocytes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Souris , Éthanol/composition chimique , Facteur de transcription associé à la microphtalmie/métabolisme , Hormone mélanotrope alpha/métabolisme , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Survie cellulaire/effets des médicaments et des substances chimiques , Mélanome expérimental/métabolisme , Lignée cellulaire tumorale , Intramolecular oxidoreductases/métabolisme
9.
Exp Dermatol ; 33(5): e15101, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38770555

RÉSUMÉ

Skin hyperpigmentation is mainly caused by excessive synthesis of melanin; however, there is still no safe and effective therapy for its removal. Here, we found that the dermal freezer was able to improve UVB-induced hyperpigmentation of guinea pigs without causing obvious epidermal damage. We also mimic freezing stimulation at the cellular level by rapid freezing and observed that freezing treatments <2.5 min could not decrease cell viability or induce cell apoptosis in B16F10 and Melan-A cells. Critically, melanin content and tyrosinase activity in two cells were greatly reduced after freezing treatments. The dramatic decrease in tyrosinase activity was associated with the downregulation of MITF, TYR, TRP-1 and TRP-2 protein expression in response to freezing treatments for two cells. Furthermore, our results first demonstrated that freezing treatments significantly reduced the levels of p-GSK3ß and ß-catenin and the nuclear accumulation of ß-catenin in B16F10 and Melan-A cells. Together, these data suggest that fast freezing treatments can inhibit melanogenesis-related gene expression in melanocytes by regulating the Wnt/ß-catenin signalling pathway. The inhibition of melanin production eventually contributed to the improvement in skin hyperpigmentation induced by UVB. Therefore, fast freezing treatments may be a new alternative of skin whitening in the clinic in the future.


Sujet(s)
Congélation , Hyperpigmentation , Mélanines , Mélanocytes , Monophenol monooxygenase , Rayons ultraviolets , Voie de signalisation Wnt , bêta-Caténine , Animaux , Mélanines/biosynthèse , Mélanines/métabolisme , Mélanocytes/métabolisme , Souris , Hyperpigmentation/métabolisme , bêta-Caténine/métabolisme , Monophenol monooxygenase/métabolisme , Cochons d'Inde , Facteur de transcription associé à la microphtalmie/métabolisme , Survie cellulaire , Intramolecular oxidoreductases/métabolisme , Glycogen synthase kinase 3 beta/métabolisme , Apoptose , Oxidoreductases/métabolisme , Interféron de type I , Protéines de la grossesse
10.
Mar Drugs ; 22(5)2024 Apr 29.
Article de Anglais | MEDLINE | ID: mdl-38786597

RÉSUMÉ

Abnormal melanogenesis can lead to hyperpigmentation. Tyrosinase (TYR), a key rate-limiting enzyme in melanin production, is an important therapeutic target for these disorders. We investigated the TYR inhibitory activity of hydrolysates extracted from the muscle tissue of Takifugu flavidus (TFMH). We used computer-aided virtual screening to identify a novel peptide that potently inhibited melanin synthesis, simulated its binding mode to TYR, and evaluated functional efficacy in vitro and in vivo. TFMH inhibited the diphenolase activities of mTYR, reducing TYR substrate binding activity and effectively inhibiting melanin synthesis. TFMH indirectly reduced cAMP response element-binding protein phosphorylation in vitro by downregulating melanocortin 1 receptor expression, thereby inhibiting expression of the microphthalmia-associated transcription factor, further decreasing TYR, tyrosinase related protein 1, and dopachrome tautomerase expression and ultimately impeding melanin synthesis. In zebrafish, TFMH significantly reduced black spot formation. TFMH (200 µg/mL) decreased zebrafish TYR activity by 43% and melanin content by 52%. Molecular dynamics simulations over 100 ns revealed that the FGFRSP (T-6) peptide stably binds mushroom TYR via hydrogen bonds and ionic interactions. T-6 (400 µmol/L) reduced melanin content in B16F10 melanoma cells by 71% and TYR activity by 79%. In zebrafish, T-6 (200 µmol/L) inhibited melanin production by 64%. TFMH and T-6 exhibit good potential for the development of natural skin-whitening cosmetic products.


Sujet(s)
Mélanines , Mélanome expérimental , Monophenol monooxygenase , Takifugu , Danio zébré , Animaux , Mélanines/biosynthèse , Takifugu/métabolisme , Monophenol monooxygenase/antagonistes et inhibiteurs , Monophenol monooxygenase/métabolisme , Souris , Mélanome expérimental/traitement médicamenteux , Mélanome expérimental/métabolisme , Lignée cellulaire tumorale , Facteur de transcription associé à la microphtalmie/métabolisme , Muscles/effets des médicaments et des substances chimiques , Muscles/métabolisme , Intramolecular oxidoreductases/métabolisme , Récepteur de la mélanocortine de type 1/métabolisme , Simulation de dynamique moléculaire , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme
11.
Br Poult Sci ; 65(3): 259-264, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38578288

RÉSUMÉ

1. This study focused on the relationship between MITF mRNA expression and plumage colour in quail and the effect of promoter methylation on the expression of MITF mRNA.2. The CDS region of MITF mRNA was cloned by RT-PCR, followed by DNA sequencing. The RT-qPCR method was used to analyse the expression levels of MITF mRNA in dorsal skin tissue in Korean quail and Beijing white quail. The promoter region of the MITF gene was cloned, and the CpG island was predicted by the CpGplot program. The methylation levels of the CpG island were analysed using BS-PCR technology.3. Quail MITF mRNA contains a 1,476 bp complete ORF, which encodes a 492 amino acid residue protein. The MITF protein has no signal peptide or transmembrane region. The expression of MITF mRNA in dorsal tissue of Korean quail was significantly higher than that in Beijing white quail (p < 0.01). Abundant cis-elements and a 346 bp CpG island were found in the promoter region of the MITF gene. The average methylation level of the CpG island was 22 (22%) in Korean quail, and 46 (30%) in Beijing white quail (p < 0.05).4. The hypermethylation of the MITF gene promoter region in Beijing white quail resulted in a decrease in expression level, which was related to white feather colour.


Sujet(s)
Coturnix , Ilots CpG , Méthylation de l'ADN , Plumes , Facteur de transcription associé à la microphtalmie , Pigmentation , Régions promotrices (génétique) , Animaux , Facteur de transcription associé à la microphtalmie/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Plumes/composition chimique , Coturnix/génétique , Coturnix/métabolisme , Coturnix/physiologie , Pigmentation/génétique , Protéines aviaires/génétique , Protéines aviaires/métabolisme , ARN messager/métabolisme , ARN messager/génétique , Expression des gènes , Séquence nucléotidique , Séquence d'acides aminés , Mâle
12.
Mar Biotechnol (NY) ; 26(3): 432-446, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38607523

RÉSUMÉ

Shell color as an important economic trait is also the crucial target trait for breeding and production. MicroRNA (miRNA) is an endogenous small non-coding RNA that can post-transcriptionally regulate the expression of target genes, it plays important roles in many life activities and physiological processes, such as shell color, stress response, and disease traits. In this study, we investigated the function of lgi-miR-2d in shell melanin formation and the expression patterns of lgi-miR-2d and target gene Rpmitf in Manila clam Ruditapes philippinarum. We further explored and verified the relationship between Rpmitf and lgi-miR-2d and identified the expression level of shell color-related gene changes by RNAi and injecting the antagomir of lgi-miR-2d, respectively. Our results indicated that lgi-miR-2d antagomir affected the expression of its target gene Rpmitf. In addition, the dual-luciferase reporter assay was conducted to confirm the direct interaction between lgi-miR-2d and Rpmitf. The results showed that the expression levels of melanin-related genes such as Rpmitf and tyr were significantly decreased in the positive treatment group compared with the blank control group after the Rpmitf dsRNA injection, indicating Rpmitf plays a crucial role in the melanin synthesis pathway. Taken together, we speculated that lgi-miR-2d might be negatively modulating Rpmitf, which might regulate other shell color-related genes, thereby affecting melanin synthesis in R. philippinarum.


Sujet(s)
Coquilles d'animaux , Bivalvia , Mélanines , microARN , Facteur de transcription associé à la microphtalmie , Animaux , Mélanines/métabolisme , Mélanines/biosynthèse , microARN/génétique , microARN/métabolisme , Bivalvia/génétique , Bivalvia/métabolisme , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Coquilles d'animaux/métabolisme , Pigmentation/génétique , Régulation de l'expression des gènes , Interférence par ARN
13.
Mar Biotechnol (NY) ; 26(3): 460-474, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38613620

RÉSUMÉ

Colorful shells in bivalves are mostly caused by the presence of biological pigments, among which melanin is a key component in the formation of shell colours. Cyclic adenosine monophosphate (cAMP) is an important messenger in the regulation of pigmentation in some species. However, the role of cAMP in bivalve melanogenesis has not yet been reported. In this study, we performed in vitro and in vivo experiments to determine the role of cAMP in regulating melanogenesis in Pacific oysters. Besides, the function of cAMP-responsive element modulator (CREM) and the interactions between CREM and melanogenic genes were investigated. Our results showed that a high level of cAMP promotes the expression of melanogenic genes in Pacific oysters. CREM controls the expression of the MITF gene under cAMP regulation. In addition, CREM can regulate melanogenic gene expression, tyrosine metabolism, and melanin synthesis. These results indicate that cAMP plays an important role in the regulation of melanogenesis in Pacific oysters. CREM is a key transcription factor in the oyster melanin synthesis pathway, which plays a crucial role in oyster melanin synthesis through a cAMP-mediated CREM-MITF-TYR axis.


Sujet(s)
Modulateur de l'élément de réponse à l'AMP cyclique , AMP cyclique , Mélanines , Animaux , Mélanines/biosynthèse , Mélanines/métabolisme , AMP cyclique/métabolisme , Modulateur de l'élément de réponse à l'AMP cyclique/métabolisme , Modulateur de l'élément de réponse à l'AMP cyclique/génétique , Pigmentation/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Régulation de l'expression des gènes , Pinctada/génétique , Pinctada/métabolisme
14.
Peptides ; 177: 171215, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38608837

RÉSUMÉ

Melasma is a common skin disease induced by an increase in the content of melanin in the skin, which also causes serious physical and mental harm to patients. In this research, a novel peptide (Nigrocin-OA27) from Odorrana andersonii is shown to exert a whitening effect on C57 mice pigmentation model. The peptide also demonstrated non-toxic and antioxidant capacity, and can significantly reduce melanin content in B16 cells. Topical application effectively delivered Nigrocin-OA27 to skin's epidermal and dermal layers and exhibited significant preventive and whitening effects on the UVB-induced ear pigmentation model in C57 mice. The whitening mechanism of Nigrocin-OA27 may be related to reduced levels of the microphthalmia-associated transcription factor and the key enzyme for melanogenesis-tyrosinase (TYR). Nigrocin-OA27 also inhibited the catalytic activity by adhering to the active core of TYR, thereby reducing melanin formation and deposition. In conclusion, Nigrocin-OA27 may be a potentially effective external agent to treat melasma by inhibiting aberrant skin melanin synthesis.


Sujet(s)
Mélanines , Facteur de transcription associé à la microphtalmie , Monophenol monooxygenase , Rayons ultraviolets , Animaux , Mélanines/métabolisme , Mélanines/biosynthèse , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Souris , Monophenol monooxygenase/métabolisme , Rayons ultraviolets/effets indésirables , Peptides/pharmacologie , Peptides/composition chimique , Pigmentation de la peau/effets des médicaments et des substances chimiques , Pigmentation de la peau/effets des radiations , Souris de lignée C57BL , Peau/effets des médicaments et des substances chimiques , Peau/métabolisme , Peau/effets des radiations , Peau/anatomopathologie , Transduction du signal/effets des médicaments et des substances chimiques
15.
Arch Dermatol Res ; 316(5): 134, 2024 Apr 25.
Article de Anglais | MEDLINE | ID: mdl-38662224

RÉSUMÉ

Exploration of gene expression variations is a potential source to unravel biological pathways involved in pathological changes in body and understand the mechanism underneath. Vitiligo patients were explored for gene expression changes transcriptionally at perilesional site in comparison to normal site of same patients for melanogenesis pathway (TYR, DCT & TYRP1) cell adhesion (MMPs & TIMP1), cell survival (BCL2 & BAX1) as well as proliferation, migration & development (SOX9, SOX10 & MITF) regulatory system, using skin biopsy samples. Results were also compared with changes in gene expression for melanocytes under stress after hydrogen peroxide treatment in-vitro. Gene amplification was carried out via real time PCR. We found increased expression of proliferation, migration & development regulatory genes as well as melanogenesis pathway genes at perilesional site of patients. In-vitro study also supports induced MITF expression and disturbed melanogenesis in melanocytes under stress. Expression level ratio of cell survival regulatory genes' (BCL2/BAX1) as well as cell adhesion regulatory genes (MMPs/TIMP1) was observed upregulated at patient's perilesional site however downregulated in hydrogen peroxide treated melanocytes in-vitro. Observed upregulated gene expression at perilesional site of patients may be via positive feedback loop in response to stress to increase cell tolerance power to survive against adverse conditions. Gene expression analysis suggests better cell survival and proliferation potential at perilesional site in vitiligo patients. It seems in-vivo conditions/growth factors supports cells to fight for survival to accommodate stressed conditions.


Sujet(s)
Survie cellulaire , Peroxyde d'hydrogène , Mélanocytes , Vitiligo , Humains , Vitiligo/génétique , Vitiligo/anatomopathologie , Mélanocytes/métabolisme , Mélanocytes/anatomopathologie , Survie cellulaire/effets des médicaments et des substances chimiques , Peroxyde d'hydrogène/métabolisme , Mâle , Adulte , Femelle , Prolifération cellulaire/génétique , Peau/anatomopathologie , Peau/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Adulte d'âge moyen , Jeune adulte , Facteurs de transcription SOX-E/génétique , Facteurs de transcription SOX-E/métabolisme , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Facteur de transcription SOX-9/génétique , Facteur de transcription SOX-9/métabolisme , Biopsie , Adolescent , Adhérence cellulaire/génétique
16.
Article de Anglais | MEDLINE | ID: mdl-38604561

RÉSUMÉ

Colorful shells in mollusks are commonly attributable to the presence of biological pigments. In Pacific oysters, the inheritance patterns of several shell colors have been investigated, but little is known about the molecular mechanisms of melanogenesis and pigmentation. cAMP-response element binding proteins (CREB) are important transcription factors in the cAMP-mediated melanogenesis pathway. In this study, we characterized two CREB genes (CREB3L2 and CREB3L3) from Pacific oysters. Both of them contained a conserved DNA-binding and dimerization domain (a basic-leucine zipper domain). CREB3L2 and CREB3L3 were expressed highly in the mantle tissues and exhibited higher expression levels in the black-shell oyster than in the white. Masson-Fontana melanin staining and immunofluorescence analysis showed that the location of CREB3L2 protein was generally consistent with the distribution of melanin in oyster edge mantle. Dual-luciferase reporter assays revealed that CREB3L2 and CREB3L3 could activate the microphthalmia-associated transcription factor (MITF) promoter and this process was regulated by the level of cAMP. Additionally, we found that cAMP regulated melanogenic gene expression through the CREB-MITF-TYR axis. These results implied that CREB3L2 and CREB3L3 play important roles in melanin synthesis and pigmentation in Pacific oysters.


Sujet(s)
Crassostrea , Protéine de liaison à l'élément de réponse à l'AMP cyclique , Mélanines , Animaux , Mélanines/métabolisme , Mélanines/biosynthèse , Crassostrea/génétique , Crassostrea/métabolisme , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme , Protéine de liaison à l'élément de réponse à l'AMP cyclique/génétique , Séquence d'acides aminés , Pigmentation/génétique , Phylogenèse , Régulation de l'expression des gènes , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique ,
17.
Pigment Cell Melanoma Res ; 37(4): 430-437, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38439523

RÉSUMÉ

Tietz albinism-deafness syndrome (TADS) is a rare and severe manifestation of Waardenburg syndrome that is primarily linked to mutations in MITF. In this report, we present a case of TADS resulting from a novel c.637G>C mutation in MITF (p.Glu213Gln; GenBank Accession number: NM_000248). A 3-year-old girl presented with congenital generalized hypopigmentation of the hair, skin, and irides along with complete sensorineural hearing loss. Histopathological and electron microscopy investigations indicated that this variant did not alter the number of melanocytes in the skin but significantly impaired melanosome maturation within melanocytes. Comprehensive melanin analysis revealed marked reductions in both eumelanin (EM) and pheomelanin (PM) rather than changes in the EM-to-PM ratio observed in oculocutaneous albinism. We conducted an electrophoretic mobility shift assay to investigate the binding capability of the identified variant to DNA sequences containing the E-box motif along with other known variants (p.Arg217del and p.Glu213Asp). Remarkably, all three variants exhibited dominant-negative effects, thus providing novel insights into the pathogenesis of TADS. This study sheds light on the genetic mechanisms underlying TADS and offers a deeper understanding of this rare condition and its associated mutations in MITF.


Sujet(s)
Facteur de transcription associé à la microphtalmie , Mutation , Humains , Facteur de transcription associé à la microphtalmie/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Femelle , Enfant d'âge préscolaire , Mutation/génétique , Syndrome de Waardenburg/génétique , Syndrome de Waardenburg/anatomopathologie , Mélanines/métabolisme , Surdité/génétique , Surdité/anatomopathologie , Gènes dominants , Mélanosomes/métabolisme , Mélanosomes/ultrastructure , Mélanosomes/génétique , Mélanocytes/anatomopathologie , Mélanocytes/métabolisme
18.
J Microbiol Biotechnol ; 34(4): 949-957, 2024 Apr 28.
Article de Anglais | MEDLINE | ID: mdl-38480002

RÉSUMÉ

There has been a growing interest in skin beauty and antimelanogenic products. Melanogenesis is the process of melanin synthesis whereby melanocytes are activated by UV light or hormone stimulation to produce melanin. Melanogenesis is mediated by several enzymes, such as tyrosinase (TYR), microphthalmia-associated transcription factor (MITF), tyrosinase-related protein-1 (TRP-1), and TRP-2. In this study, we investigated the effect of Tuber himalayense extract on melanin synthesis in α-melanocyte-stimulating hormone (α-MSH)-treated B16F10 melanoma cells. We confirmed that T. himalayense extract was not toxic to α-MSH-treated B16F10 melanoma cells and exhibited a significant inhibitory effect on melanin synthesis at concentrations of 25, 50, and 100 µg/ml. Additionally, the T. himalayense extract inhibited melanin, TRP-1, TRP-2, tyrosinase, and MITF, which are enzymes involved in melanin synthesis, in a concentration-dependent manner. Furthermore, T. himalayense extract inhibited the mitogen-activated protein kinase (MAPK) pathways, such as extracellular signal-regulated kinase-1/2 (ERK), c-Jun N-terminal kinase (JNK), and p38. Therefore, we hypothesized that various components of T. himalayense extract affect multiple factors involved in melanogenesis in B16F10 cells. Our results indicate that T. himalayense extract could potentially be used as a new material for preparing whitening cosmetics.


Sujet(s)
Mélanines , Facteur de transcription associé à la microphtalmie , Monophenol monooxygenase , Extraits de plantes , Mélanines/biosynthèse , Mélanines/métabolisme , Animaux , Souris , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Monophenol monooxygenase/antagonistes et inhibiteurs , Monophenol monooxygenase/métabolisme , Lignée cellulaire tumorale , République de Corée , Facteur de transcription associé à la microphtalmie/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Intramolecular oxidoreductases/métabolisme , Hormone mélanotrope alpha/pharmacologie , Hormone mélanotrope alpha/métabolisme , Mélanome expérimental/métabolisme , Oxidoreductases/métabolisme , Tubercules/composition chimique , Glycoprotéines membranaires/métabolisme , Mélanocytes/effets des médicaments et des substances chimiques , Mélanocytes/métabolisme , Survie cellulaire/effets des médicaments et des substances chimiques
19.
Oncogene ; 43(20): 1489-1505, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38519642

RÉSUMÉ

Cell plasticity sustains intra-tumor heterogeneity and treatment resistance in melanoma. Deciphering the transcriptional mechanisms governing reversible phenotypic transitions between proliferative/differentiated and invasive/stem-like states is required. Expression of the ZEB1 transcription factor is frequently activated in melanoma, where it fosters adaptive resistance to targeted therapies. Here, we performed a genome-wide characterization of ZEB1 transcriptional targets, by combining ChIP-sequencing and RNA-sequencing, upon phenotype switching in melanoma models. We identified and validated ZEB1 binding peaks in the promoter of key lineage-specific genes crucial for melanoma cell identity. Mechanistically, ZEB1 negatively regulates SOX10-MITF dependent proliferative/melanocytic programs and positively regulates AP-1 driven invasive and stem-like programs. Comparative analyses with breast carcinoma cells revealed lineage-specific ZEB1 binding, leading to the design of a more reliable melanoma-specific ZEB1 regulon. We then developed single-cell spatial multiplexed analyses to characterize melanoma cell states intra-tumoral heterogeneity in human melanoma samples. Combined with scRNA-Seq analyses, our findings confirmed increased ZEB1 expression in Neural-Crest-like cells and mesenchymal cells, underscoring its significance in vivo in both populations. Overall, our results define ZEB1 as a major transcriptional regulator of cell states transitions and provide a better understanding of lineage-specific transcriptional programs sustaining intra-tumor heterogeneity in melanoma.


Sujet(s)
Régulation de l'expression des gènes tumoraux , Mélanome , Facteur de transcription Zeb1 , Facteur de transcription Zeb1/génétique , Facteur de transcription Zeb1/métabolisme , Mélanome/génétique , Mélanome/anatomopathologie , Mélanome/métabolisme , Humains , Lignée cellulaire tumorale , Lignage cellulaire/génétique , Facteurs de transcription SOX-E/génétique , Facteurs de transcription SOX-E/métabolisme , Facteur de transcription associé à la microphtalmie/génétique , Facteur de transcription associé à la microphtalmie/métabolisme , Souris , Animaux , Prolifération cellulaire/génétique , Transcription génétique/génétique
20.
Commun Biol ; 7(1): 275, 2024 Mar 05.
Article de Anglais | MEDLINE | ID: mdl-38443437

RÉSUMÉ

Transparent immunodeficient animal models not only enhance in vivo imaging investigations of visceral organ development but also facilitate in vivo tracking of transplanted tumor cells. However, at present, transparent and immunodeficient animal models are confined to zebrafish, presenting substantial challenges for real-time, in vivo imaging studies addressing specific biological inquiries. Here, we employed a mitf-/-/prkdc-/-/il2rg-/- triple-knockout strategy to establish a colorless and immunodeficient amphibian model of Xenopus tropicalis. By disrupting the mitf gene, we observed the loss of melanophores, xanthophores, and granular glands in Xenopus tropicalis. Through the endogenous mitf promoter to drive BRAFV600E expression, we confirmed mitf expression in melanophores, xanthophores and granular glands. Moreover, the reconstruction of the disrupted site effectively reinstated melanophores, xanthophores, and granular glands, further highlighting the crucial role of mitf as a regulator in their development. By crossing mitf-/- frogs with prkdc-/-/il2rg-/- frogs, we generated a mitf-/-/prkdc-/-/il2rg-/- Xenopus tropicalis line, providing a colorless and immunodeficient amphibian model. Utilizing this model, we successfully observed intravital metastases of allotransplanted xanthophoromas and migrations of allotransplanted melanomas. Overall, colorless and immunodeficient Xenopus tropicalis holds great promise as a valuable platform for tumorous and developmental biology research.


Sujet(s)
Anura , Danio zébré , Animaux , Cytoplasme , Xenopus/génétique , Danio zébré/génétique , Facteur de transcription associé à la microphtalmie/génétique , Facteur de transcription associé à la microphtalmie/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...